|
GPD2 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.005600E-02 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.069850E-02 |
| Normal-vs-Stage2 |
9.436600E-01 |
| Normal-vs-Stage3 |
4.110600E-01 |
| Normal-vs-Stage4 |
8.506200E-01 |
| Stage1-vs-Stage2 |
7.591900E-02 |
| Stage1-vs-Stage3 |
8.838100E-02 |
| Stage1-vs-Stage4 |
5.671800E-02 |
| Stage2-vs-Stage3 |
4.825800E-01 |
| Stage2-vs-Stage4 |
8.333800E-01 |
| Stage3-vs-Stage4 |
6.151600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.784100E-02 |
| Normal-vs-AfricanAmerican |
1.896330E-02 |
| Normal-vs-Asian |
1.797360E-01 |
| Caucasian-vs-AfricanAmerican |
9.633600E-02 |
| Caucasian-vs-Asian |
9.515800E-01 |
| AfricanAmerican-vs-Asian |
1.267360E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.318600E-01 |
| Normal-vs-Female |
5.053900E-02 |
| Male-vs-Female |
5.466400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.521200E-03 |
| Normal-vs-Age(41-60Yrs) |
3.095400E-01 |
| Normal-vs-Age(61-80Yrs) |
6.966600E-01 |
| Normal-vs-Age(81-100Yrs) |
7.781000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.365900E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.017600E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.454010E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.021200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.640400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.532800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
7.956500E-03 |
| Classical-VS-Follicular |
5.022100E-04 |
| Classical-VS-Other |
1.486000E-01 |
| Classical-VS-Normal |
2.096400E-03 |
| Tall-VS-Follicular |
6.355200E-01 |
| Tall-VS-Other |
5.241800E-01 |
| Tall-VS-Normal |
9.840200E-01 |
| Follicular-VS-Other |
8.166600E-01 |
| Follicular-VS-Normal |
5.917400E-01 |
| Other-VS-Normal |
5.167200E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.961200E-01 |
| Normal-vs-N1 |
7.440600E-01 |
| N0-vs-N1 |
7.533400E-01 |
|
|
